Brain stimulation breakthrough? new technique targets cognitive decline in rare condition

NCT ID NCT07166432

Recruiting now Knowledge-focused Sponsor: Peking University First Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study is testing a new, minimally invasive brain stimulation technique for people with cerebellar cognitive affective syndrome (CCAS), a condition that causes problems with thinking, mood, and movement. The researchers are enrolling 200 participants with Cushing's syndrome-related cerebellar atrophy. They aim to see if the stimulation improves symptoms and to understand how it works at a molecular level.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: minimally-invasive bidirectional epidural cerebellar stimulation
What this could lead to: If successful, this could point toward a new treatment for cognitive and movement problems caused by cerebellar atrophy.
What could go wrong: This is an early-stage study focused on understanding how the technique works. It is small and may not lead to a proven treatment. Risks of the procedure are still being evaluated.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBELLAR ATROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebellar degeneration Cushing syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CEREBELLAR ATROPHY ETIOLOGY PHYSIOPATHOLOGY

Contacts and locations

Locations

Department of Urology, Peking University First Hospital, Beijing, 100034
RECRUITING

Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.